Improving Myeloma Outcomes
Video Categories: Hematological Malignancies
Dr. Ajai Chari discusses the ultimate goal of improving therapy for myeloma patients. He mentions the COMPASS study, which is working to collect a database of clinical and scientific information on 1000 patients. In the interim, there are some clues, such as an understanding of certain high-molecular-risk patients and some evidence of certain subgroups that have increased response to some new drugs. This allows physicians to be more selective for those who are most likely to benefit from certain therapies.
December 12, 2016
Sunil Verma, MD, MSEd, FRCPC discusses treatment options for this type of cancer.
October 1, 2014
Hear Atheer Kaddis describe how the role of the pharmacist is changing in hematology and oncology.Supported through funding from Incyte